Naveed Sattar

Amsterdam Neuroscience — Netherlands

Medicine · Health Sciences

203h-index205.6kcitations2.2kworks15.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(359), Diabetes, Cardiovascular Risks, and Lipoproteins(237), Lipoproteins and Cardiovascular Health(221), Diabetes Management and Research(164), Genetic Associations and Epidemiology(162)

Publications2.0k total

Quantifying the U.S. obesogenic environment and its quasi-causal association with obesity: a cross-sectional twin study
Health & Place·2026Open Access
Corrigendum to “The effect of preprandial versus postprandial physical activity on glycaemia: Meta-analysis of human intervention studies”. [Diabetes Res. Clin. Pract. 210 (2024) 111638]
Diabetes Research and Clinical Practice·2026Open Access
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
New England Journal of Medicine·2025· 10 citedOpen Access
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
JAMA Cardiology·2025· 2 cited
Social learning theories and metabolic health: the centenary of Bandura's birth
The Lancet Diabetes & Endocrinology·2025
Derivation and Definitions of Clinical Study Variables for Multiple Long Term Conditions in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Modified Delphi Methods and Consensus Study on Behalf of the International Cardiovascular and Respiratory Alliance
Pragmatic and Observational Research·2025Open Access
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study
The Lancet Regional Health - Europe·2025Open Access
Atherosclerotic Cardiovascular Risk Before and After Type 2 Diabetes Onset and the Roles of Ectopic Fat and Ethnic Variation: The 2025 Edwin Bierman Award Lecture
Diabetes·2025· 1 citedOpen Access
Incretin therapy for cardiovascular disease: opportunities, mechanistic gaps, and challenges
European Heart Journal·2025
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care
Diabetes Care·2025Open Access
Tirzepatide and change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial
Annals of the Rheumatic Diseases·2025Open Access
Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people
Diabetes Obesity and Metabolism·2025Open Access
Abstract 4343615: Improvements in Cardiometabolic Risk Factors by Body Weight Reduction with Tirzepatide in Adults with Obesity and Prediabetes: A Post Hoc Analysis of the 3-year SURMOUNT-1 study
Circulation·2025
S102 The potential effect of glucagon-like peptide 1 receptor agonists (GLP1s) on chronic obstructive pulmonary disease (COPD) exacerbations, a case control analyses
2025
Ethnic differences in HDL quantity, quality, and potential associations with coronary heart disease risk
Atherosclerosis·2025Open Access
Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies
Diabetologia·2025· 6 citedOpen Access
Waist, waist-height-ratio vs body mass index and the risks of multiple diseases: a cohort study with replication
2025Open Access
Author response for "Progressive increases in adiposity and ectopic fat surrogates across glycaemic states highlight weight reduction as a key target for type 2 diabetes prevention, especially in younger people"
2025
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International·2025· 1 citedOpen Access
Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK
European Journal of Preventive Cardiology·2025· 1 citedOpen Access
page 1 of 102Next →

Frequent Co-authors

Ian Ford(9), Emanuele Di Angelantonio(7), Iain B. McInnes(7), Massimo Piepoli(6), Chris J. Packard(6), Arno W. Hoes(5), Bernard Cosyns(5), Christi Deaton(5), Oscar H. Franco(5), Piotr Ponikowski(5), Victor Aboyans(5), Nikolaus Marx(5), Kamlesh Khunti(5), John Danesh(5), John J.V. McMurray(5), J. Wouter Jukema(5), Maja‐Lisa Løchen(4), Pedro Marques‐Vidal(4), Joep Perk(4), Eva Prescott(4)